[go: up one dir, main page]

DK3810587T3 - Substituerede alkoxypyridinylindolsulfonamider - Google Patents

Substituerede alkoxypyridinylindolsulfonamider Download PDF

Info

Publication number
DK3810587T3
DK3810587T3 DK19731283.8T DK19731283T DK3810587T3 DK 3810587 T3 DK3810587 T3 DK 3810587T3 DK 19731283 T DK19731283 T DK 19731283T DK 3810587 T3 DK3810587 T3 DK 3810587T3
Authority
DK
Denmark
Prior art keywords
alkoxypyridinylindolesulfonamides
substituted
substituted alkoxypyridinylindolesulfonamides
Prior art date
Application number
DK19731283.8T
Other languages
English (en)
Inventor
Cécile Pegurier
Laurent Provins
Emre M Isin
Marie Ledecq
Original Assignee
Ucb Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Gmbh filed Critical Ucb Pharma Gmbh
Application granted granted Critical
Publication of DK3810587T3 publication Critical patent/DK3810587T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK19731283.8T 2018-06-20 2019-06-19 Substituerede alkoxypyridinylindolsulfonamider DK3810587T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18178773.0A EP3584244A1 (en) 2018-06-20 2018-06-20 Substituted alkoxypyridinyl indolsulfonamides
PCT/EP2019/066148 WO2019243398A1 (en) 2018-06-20 2019-06-19 Substituted alkoxypyridinyl indolsulfonamides

Publications (1)

Publication Number Publication Date
DK3810587T3 true DK3810587T3 (da) 2022-10-31

Family

ID=62715911

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19731283.8T DK3810587T3 (da) 2018-06-20 2019-06-19 Substituerede alkoxypyridinylindolsulfonamider

Country Status (14)

Country Link
US (1) US11976056B2 (da)
EP (3) EP3584244A1 (da)
JP (1) JP7371031B2 (da)
CN (1) CN112292375B (da)
CA (1) CA3101086A1 (da)
DK (1) DK3810587T3 (da)
ES (1) ES2929829T3 (da)
HR (1) HRP20221289T1 (da)
HU (1) HUE060181T2 (da)
LT (1) LT3810587T (da)
MX (1) MX2020012823A (da)
PL (1) PL3810587T3 (da)
PT (1) PT3810587T (da)
WO (1) WO2019243398A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7631235B2 (ja) * 2019-06-17 2025-02-18 ウーツェーベー ファルマ ゲーエムベーハー 多発性硬化症のようなcns障害を治療するためのgpr17モジュレーターとしてのn‐(フェニル)‐インドール‐3‐スルホンアミド誘導体及び関連化合物
JP2023531358A (ja) * 2020-05-01 2023-07-24 ザ チルドレンズ メディカル センター コーポレーション ミエリン形成を促進する組成物および方法
CN112375027B (zh) * 2020-12-07 2023-03-31 中国药科大学 吲哚磺酰胺类衍生物及其医药用途
MX2023009045A (es) * 2021-02-26 2023-08-10 Hoffmann La Roche Derivados novedosos de pirimidin-2-il sulfonamida.
EP4311828A1 (en) * 2022-07-26 2024-01-31 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
WO2023241960A1 (en) * 2022-06-15 2023-12-21 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
EP4558496A1 (en) * 2022-07-20 2025-05-28 F. Hoffmann-La Roche AG Novel pyrimidinyl and triazinyl sulfonamide derivatives
CN119585264A (zh) * 2022-07-20 2025-03-07 豪夫迈·罗氏有限公司 新颖异噻唑-3-基和异噁唑-3-基磺酰胺化合物
EP4558479A1 (en) * 2022-07-20 2025-05-28 F. Hoffmann-La Roche AG Novel naphthyl and isoquinoline sulfonamide derivatives
JP2025525574A (ja) 2022-07-20 2025-08-05 エフ. ホフマン-ラ ロシュ アーゲー 新規のイミダゾピリジンおよびピラゾロピリジンスルホンアミド誘導体
CN119546576A (zh) 2022-07-20 2025-02-28 豪夫迈·罗氏有限公司 新颖的异喹啉酮、吡咯并吡啶酮和噻吩并吡啶酮磺酰胺衍生物
JP2025524062A (ja) * 2022-07-28 2025-07-25 エフ. ホフマン-ラ ロシュ アーゲー 新規7-置換インドールスルホンアミド誘導体
KR20250042748A (ko) * 2022-07-28 2025-03-27 에프. 호프만-라 로슈 아게 신규 7-치환 인돌 설폰아미드 유도체
PE20251077A1 (es) * 2022-08-26 2025-04-10 Hoffmann La Roche Derivados novedosos deuterados de pirimidin-2-il sulfonamida
AU2023401169A1 (en) * 2022-12-02 2025-05-29 Rewind Therapeutics Nv Fused pyrrolyl-sulfonamide compounds
WO2024153233A1 (en) * 2023-01-19 2024-07-25 Nanjing Immunophage Biotech Co., Ltd Compounds and their uses as gpr17 antagonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
SE9904750D0 (sv) 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
WO2005103291A1 (ja) 2004-04-27 2005-11-03 Takeda Pharmaceutical Company Limited Gタンパク質共役型レセプタータンパク質の新規リガンドとその用途
ITMI20042007A1 (it) 2004-10-21 2005-01-21 Consiglio Nazionale Ricerche "modulatori del ricettore gpr17 e loro impieghi terapeutici"
MX2008007897A (es) 2005-12-20 2009-03-04 Teikoku Pharma Usa Inc Metodos para administrar transdermicamente un agonista de receptor de indol serotonina y composiciones transdermicas para uso con los mismos.
EP2162183B1 (de) 2007-06-25 2019-06-26 AMW GmbH Elektrophoretisches transdermales applikationssystem
US20120172375A1 (en) * 2008-11-07 2012-07-05 Bruce Trapp Compounds and methods of promoting oligodendrocyte precursor differentiation
WO2011113032A2 (en) 2010-03-11 2011-09-15 Swinford Jerry L Method and apparatus for washing dowhole tubulars and equipment
EP2567698B1 (en) * 2011-09-07 2014-02-12 Rheinische Friedrich-Wilhelms-Universität Bonn GPR 17 agonists and screening assay
JP6082457B2 (ja) 2012-05-09 2017-02-15 ウニヴェルスィタ デッリ ストゥディ ディ ミラノ Gpr17受容体調節因子
WO2018057989A1 (en) * 2016-09-24 2018-03-29 Washington University INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF
TWI754702B (zh) * 2016-12-28 2022-02-11 德商Ucb製藥有限公司 (氮雜)吲哚-和苯並呋喃-3-磺醯胺類

Also Published As

Publication number Publication date
EP3810587B1 (en) 2022-08-10
PT3810587T (pt) 2022-11-14
CN112292375B (zh) 2023-12-05
EP3584244A1 (en) 2019-12-25
LT3810587T (lt) 2022-11-25
WO2019243398A1 (en) 2019-12-26
HRP20221289T1 (hr) 2022-12-23
JP2021527696A (ja) 2021-10-14
JP7371031B2 (ja) 2023-10-30
PL3810587T3 (pl) 2023-02-06
HUE060181T2 (hu) 2023-02-28
EP3810587A1 (en) 2021-04-28
CN112292375A (zh) 2021-01-29
MX2020012823A (es) 2021-02-15
US11976056B2 (en) 2024-05-07
CA3101086A1 (en) 2019-12-26
US20210214337A1 (en) 2021-07-15
EP4086248A1 (en) 2022-11-09
ES2929829T3 (es) 2022-12-01

Similar Documents

Publication Publication Date Title
FIC20253006I1 (fi) Linvoseltamabi
EP3846674C0 (en) VAGINAL SPECULUM
EP3849534A4 (en) COMBINATION THERAPIES
DK3810587T3 (da) Substituerede alkoxypyridinylindolsulfonamider
EP3781060A4 (en) CRYOPROBE
EP3784463A4 (en) Fluorosulfones
EP3805381A4 (en) Phytase mutant
EP3872558A4 (en) OPTICAL ISOLATOR
EP3810860C0 (en) COUPLER
EP3760247A4 (en) TOXIN SEPARATOR
EP3760771A4 (en) MULTIFILAMENT OF POLYAMIDE 610
EP3891095C0 (en) POLYMER OPAL
EP3721129A4 (en) CRYOSPHERE
EP3878374A4 (en) Occlusion device
EP3844177A4 (en) COMBINATION THERAPIES
EP3805997A4 (en) Lipid nanotablet
EP3773733A4 (en) METALLO-LIOTHYRONINE
DK3587968T3 (da) Fluidsystem
EP3787554A4 (en) STENT TRANSPLANT
DK3752258T3 (da) Trampolin
EP3740063A4 (en) Epichloë endophyte
EP3738602A4 (en) CYTOCIDE
ES1207586Y (es) Furgo-caravana
EP3797079A4 (en) CRYOGENIC COATING
EP3787995C0 (en) HARNESS SADDLE